Skip to main content
Log in

Serum neuron specific enolase: Can it be a tumour marker for renal cell carcinoma?

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Neuron specific enolase (NSE) is an isoenzyme of the glycolytic enzyme enolase. It is not only a marker for all types of neurons but also for all neuroendocrine or paraneuronal cells and various malignant tumours, even of non-neuroendocrine types.

We had studied serum NSE in 25 consecutive patients with renal cell carcinoma (RCC). The study included 10 stage I, 3 stage II, 3 stage III-B and 9 stage IV-B patients. Both pretreatment and posttreatment levels were evaluated. Regardless of stage, overall we observed elevated levels of NSE in 80% (20/25) at diagnosis. After the appropriate treatment, according to the stage, there had been a statistically significant (p<0.05) decrease in the serum levels in all stage I, II and III-B patients. The posttreatment values were not available for stage IV-B patients because they did not come for follow-up.

The preliminary results of our study revealed that serum NSE may be considered as a useful marker in the evaluation and surveillance of RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. deKernion, J. B., Nelldegrun, A.: Renal tumors. In: Walsh, P., Retik, A., Stamey, T., Vaughan, D. (eds). Campbell's Urology, Vol. 2, 6th edition. W. B. Saunders Co., Philadelphia 1992, pp. 1053–1093.

    Google Scholar 

  2. Kaiser, E., Kuzmits, P., Pregant, P., Burghuber, O., Worofka, W.: Clinical biochemistry of neuron specific enolase.Clin. Chim. Acta, 183, 13 (1989).

    Article  PubMed  CAS  Google Scholar 

  3. Tapia, F., Polak, J., Barboas, A., Bloom, S., Marangos, P., Dermody, C., Pearse, A.: Neuron specific enolase is produced by neuroendocrine tumors.Lancet, i, 808 (1981).

    Article  Google Scholar 

  4. Akoun, G., Scarna, H., Milleron, B., Benichou, M., Herman, D.: Serum neuron specific enolase. A marker for disease extent and response to therapy for small cell lung cancer.Chest, 87, 39 (1985).

    PubMed  CAS  Google Scholar 

  5. Haimoto, H., Takashi, M., Koshikawa, T., Asai, J., Kato, K.: Enolase isozymes in renal tubules and renal cell carcinoma.Am. J. Pathol., 124, 488 (1986).

    PubMed  CAS  Google Scholar 

  6. Takashi, M., Haimoto, H., Tanaka, J.: Evaluation of gamma-enolase as a tumor marker for renal cell carcinoma.J. Urol., 141, 831 (1989).

    Google Scholar 

  7. Gross, A. J., Michl, U. H., Bornhöft, G., Dieckmann, P.: Neuron specific enolase: A serum tumor marker in renal cell carcinoma?Eur. Urol., 24, 397 (1993).

    PubMed  CAS  Google Scholar 

  8. Cohen, C., McCue, P., Derosa, P.: Histogenesis of renal cell carcinoma and renal oncocytoma.Cancer, 62, 1946 (1988).

    Article  PubMed  CAS  Google Scholar 

  9. Geast, A., Putten, W., Oosterom, R.: Prognostic value of serum thymidine kinase and neuron specific enolase with small cell lung cancer.Br. J. Cancer, 64 (2), 369 (1991).

    Google Scholar 

  10. Zandwick, N., Jassem, E., Bonfrer, J.: Value of neuron specific enolase in early detection of relapse in small cell carcinoma.Eur. J. Cancer, 26, 373 (1990).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yaman, Ö., Baltaci, S., Arikan, N. et al. Serum neuron specific enolase: Can it be a tumour marker for renal cell carcinoma?. International Urology and Nephrology 28, 207–210 (1996). https://doi.org/10.1007/BF02550862

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02550862

Keywords

Navigation